Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRTA8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,885
Award facts
- Contract value 100% obligated
- $14,884.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,884.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform delivery at its corporate office location. Zepbound is a GLP-1 receptor agonist used for weight management, indicating the federal military healthcare system's procurement of this medication to support beneficiary health outcomes.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems through its comprehensive global pharmaceutical support vehicle with the DLA. The company's extensive portfolio of federal medical supply contracts demonstrates its capability to deliver a wide range of medications and medical commodities across multiple therapeutic domains on a competitively awarded basis. This delivery order reflects the ongoing utilization of the pharmaceutical prime vendor contract to fulfill specific medication requirements for Defense Health Agency customers and other federal healthcare beneficiaries within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRTA8?
SPE2DB25FRTA8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FRTA8 worth?
The government has obligated $14,885 on SPE2DB25FRTA8.
Is contract SPE2DB25FRTA8 an order under another contract?
Yes. SPE2DB25FRTA8 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRTA8 competed?
The extent of competition for SPE2DB25FRTA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award